Maxim Group maintains Buy on Oxbridge Re, lowers target to $3

scanx
Reviewed by
Radhika SScanX News Team
Key Highlights

Maxim Group analyst Allen Klee maintains a Buy rating on Oxbridge Re Holdings but lowers the price target from $5 to $3.

powered bylight_fuzz_icon
43268174

*this image is generated using AI for illustrative purposes only.

Maxim Group analyst Allen Klee has maintained a Buy rating on Oxbridge Re Holdings while adjusting the valuation outlook. The price target has been reduced to $3 from the previous $5.

The revised target reflects a reassessment of the company's stock potential despite the continued positive recommendation. The rating indicates that Maxim Group still expects the shares to perform well relative to the broader market.

Metric Value
Rating Buy
New Price Target $3
Previous Price Target $5
Disclaimer: This article is AI-generated using data from ViewTrade. ScanX is not liable for any inaccuracies.

What specific factors led to the reassessment of Oxbridge Re Holdings' valuation potential?

How might this price target reduction influence investor sentiment in the short term?

What are the key growth drivers that could help the stock reach the new $3 price target?

like18
dislike

SurancePlus exceeds return targets on tokenized reinsurance offerings

scanx
Reviewed by
Shriram SScanX News Team
Key Highlights

SurancePlus reported annualized returns of 29.3% and 43.4% for its EtaCat Re and ZetaCat Re offerings, exceeding original targets of 20% and 42%. Oxbridge Re Holdings Limited also fully repaid a $1.0 million promissory note, eliminating outstanding debt.

powered bylight_fuzz_icon
42669207

*this image is generated using AI for illustrative purposes only.

Oxbridge Re Holdings Limited, through its subsidiary SurancePlus, announced annualized returns of 29.3% and 43.4% for investors in its 2025-2026 EtaCat Re and ZetaCat Re tokenized reinsurance offerings. These returns exceeded the offerings' original target returns of 20% and 42%, respectively. The results demonstrate the ability of SurancePlus's tokenized real-world asset (RWA) platform to provide investors with access to institutional-quality reinsurance investments and attractive risk-adjusted returns.

The performance highlights the strength of SurancePlus's underwriting strategy and validates the growing demand for tokenized real-world assets. By providing direct access to reinsurance opportunities through a transparent, blockchain-based structure, the company offers exposure to an asset class that is not correlated to the capital markets.

Oxbridge Re Holdings Limited also announced that it has fully repaid the $1.0 million short-term promissory note previously disclosed on February 11, 2026, together with all accrued interest. Following this repayment, Oxbridge has no outstanding debt obligations on its balance sheet. This development strengthens the company's financial position and provides additional flexibility to pursue its strategic growth initiatives.

Offering Target Return Actual Annualized Return
EtaCat Re 20% 29.3%
ZetaCat Re 42% 43.4%

Jay Madhu, Chairman and CEO of Oxbridge and SurancePlus, commented that the results validate the company's underwriting approach. He emphasized that the performance demonstrates the strength of tokenized reinsurance as an investable asset class and reinforces the value of providing investors access to institutional-quality reinsurance opportunities through a transparent blockchain-based structure.

Disclaimer: This article is AI-generated using data from ViewTrade. ScanX is not liable for any inaccuracies.

Will Oxbridge Re expand its tokenized reinsurance offerings to new lines of business or geographic markets in 2027?

How might the success of EtaCat Re and ZetaCat Re influence institutional adoption of tokenized real-world assets?

What strategic growth initiatives will Oxbridge Re prioritize now that it has a debt-free balance sheet?

like16
dislike